NASDAQ:TVTX

Travere Therapeutics Stock Predictions

etoro logo Buy TVTX
*Your capital is at risk
$45.20
+2.24 (+5.21%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

TVTX Prediction Chart

TVTX Predictions History

Latest community submissions for TVTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 15, 2026 $41.09 -2.46% $40.95 V 99.65% 5
Apr 15, 2026 $41.48 -1.54% $40.95 V 98.70% 2
Apr 15, 2026 Bullish $40.95 V 0
Nov 12, 2025 $35.40 -1.96% $36.47 X 97.08% 0
Nov 12, 2025 $35.67 -1.22% $36.47 X 97.80% 0
Nov 12, 2025 Bullish $36.47 V 1
May 5, 2025 $20.68 -2.20% $21.41 X 96.61% 0
May 5, 2025 $20.86 -1.38% $21.41 X 97.43% 0
May 5, 2025 Bullish $21.41 V 1
JS JS Pro
Jan 18, 2024 $9.29 +0.65% $8.88 X 95.38% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TVTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT TRAVERE THERAPEUTICS, INC.
Travere Therapeutics
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzy...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE